India, with its diverse climatic conditions and high population density, presents a significant burden of vector-borne diseases (VBDs). These diseases, transmitted by vectors such as mosquitoes, ticks, and flies, pose substantial challenges to the public health system.
India is endemic to several VBDs, including malaria, dengue, chikungunya, and Japanese encephalitis. Despite concerted efforts, India accounts for 4% of global malaria cases. Dengue cases have shown an alarming rise, with a 300% increase in the past decade. Chikungunya and Japanese encephalitis also persistently contribute to the disease burden.
VBDs cause significant morbidity and mortality, straining India's healthcare system. They disrupt socio-economic development and pose a substantial threat to the achievement of the Sustainable Development Goals. The economic burden of these diseases is immense, with an estimated annual cost of USD 1.34 billion for malaria alone.
India's fight against VBDs is marred by inadequate surveillance, limited resources, and climate change. However, opportunities exist in the form of improved diagnostic tools, vector control strategies, and vaccines. The recent launch of the National Vector Borne Disease Control Programme (NVBDCP) signifies a step in the right direction.
Vector-borne diseases remain a significant public health challenge in India, necessitating a comprehensive, multi-pronged approach. There is a pressing need for improved surveillance, early diagnosis, effective management, and preventive measures. As healthcare professionals, our role extends beyond clinical management to advocacy, research, and education, contributing to a robust response against VBDs.
1.
Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Weight loss trial reports success for breast cancer patients at one year mark
4.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
5.
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients
1.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
2.
Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders
3.
AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis
4.
Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential
5.
Epigenetic Subtyping of Complex Hematologic Disorders
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Updates on the First Line Management of ALK+ NSCLC
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation